-

Japan Renewables Alert 71
As our Japan Renewables Alerts usually provide updates on important regulatory amendments in the renewable field, this issue provides an overview of the market landscape by introducing some of our recent activities….By: Orrick, Herrington & Sutcliffe LLP
-

UK High Court: landmark decision on copyright and Gen AI – Stability AI only liable for “extremely limited”, historical trade mark infringement and no UK copyright infringement
In a highly anticipated judgment handed down on 4 November 2025, the High Court held that Stability AI is not liable for copyright infringement arising from the download of copies of Stable Diffusion in the UK from online locations outside the UK (secondary infringement). Stability AI is liable however, for extremely limited, historical trade mark…
-

Justices’ Age Verification Ruling May Lead To More State Laws
The digital age presents a complex challenge: protecting children online while also allowing free speech to continue to be a thriving marketplace of ideas. Originally published in Law360 – August 4, 2025….By: Troutman Pepper Locke
-

58. November 4, 2025 | Reducing the 20% IEEPA-fentanyl tariffs on China to 10%; Reciprocal Tariffs on China Remain at 10% until November 2026
International Emergency Economic Powers Act (50 U.S.C. 1701 et seq.) (IEEPA), the National Emergencies Act (50 U.S.C. 1601 et seq.), section 604 of the Trade Act of 1974, as amended (19 U.S.C. 2483), and section 301 of title 3, United States Code…By: Thompson Coburn LLP
-

What Happens When You’re Offered a Settlement for Your Personal Injury?
When you’ve been hurt in a motor vehicle accident or other incident caused by someone else’s irresponsible actions, you often have the option to file a personal injury lawsuit to require the person who caused your injuries to compensate you for the harm they’ve caused….By: Searcy Denney Scarola Barnhart & Shipley
-

Texas Sues Johnson & Johnson and Kenvue Over Tylenol: Scientific Evidence, Regulatory Shifts, and the Future of OTC Drug Labeling
On October 28, 2025, the State of Texas filed a complaint against Johnson & Johnson and Kenvue, Inc. (“Kenvue”)—formerly the consumer health division of Johnson & Johnson, and now in the process of being acquired by Kimberly-Clark—alleging deceptive marketing and fraudulent financial moves related to Tylenol (acetaminophen) (the “Lawsuit”)….By: Sheppard Mullin Richter & Hampton LLP
-

Depo Provera Lawsuit: Litigation Update and Settlement Information
Pfizer Inc. is facing a growing number of lawsuits from patients who received Depo Provera injections—including patients who received their last injection decades ago in some cases. Depo Provera (medroxyprogesterone acetate) is an injectable birth control shot used by millions of women across the United States. Now, however, lawsuits filed by women who received Depo…
-

Russia Close to Its Biggest Capture of a Ukrainian City Since 2023
The Kremlin is focusing its fire on Pokrovsk, a gateway to the Donetsk region, which Russia’s president, Vladimir V. Putin, has long coveted.
-

Philippines Faces Grim Typhoon Aftermath as Another Storm Nears
As the death toll for Typhoon Kalmaegi rose into the triple digits, the country braced for another storm expected this weekend.
-

Canada Is About to Lose Its Status as Having Eliminated Measles
One province with an outsize number of cases has seen a collision of politics and public health policy.